Vertex will pay Editas Medicine and the Broad Institute millions for rights to their CRISPR patent
The patent on CRISPR has been the fulcrum off a decade-long legal fight after the Broad Institute, a research center in Cambridge, Massachusetts, snatched rights to the most important uses of the gene-editing tool in 2014. Broad’s patent claims have been opposed by the University of California, Berkeley, which says researchers Jennifer Doudna and Emmanuelle Charpentier are the tool’s true inventors. The pair won a Nobel Prize in 2020 for their work on the technology.
An exclusive license to the Broad Institute patent…